Clinical trials
Phase 1/2 Rhabdomyosarcoma trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 1 |
| Bristol-Myers Squibb | 1 |
| Celgene | 1 |
| Eisai Inc. | 1 |
| Eli Lilly and Company | 1 |
| GlaxoSmithKline | 1 |
| University of Birmingham | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rhabdomyosarcoma | 7 |
| Sarcoma, Ewing | 4 |
| Ependymoma | 3 |
| Melanoma | 3 |
| Neuroblastoma | 3 |
| Osteosarcoma | 3 |
| Diffuse Intrinsic Pontine Glioma | 2 |
| Glioblastoma | 2 |
| Glioma | 2 |
| Medulloblastoma | 2 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.